Mesa Laboratories (MLAB) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
241.0M
Gross Profit
150.9M
62.61%
Operating Income
16.3M
6.78%
Net Income
-2.0M
-0.82%
Balance Sheet Metrics
Total Assets
433.3M
Total Liabilities
273.5M
Shareholders Equity
159.8M
Debt to Equity
1.71
Cash Flow Metrics
Operating Cash Flow
39.7M
Free Cash Flow
42.3M
Revenue & Profitability Trend
Mesa Laboratories Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 241.0M | 216.2M | 219.1M | 184.3M | 133.9M |
| Cost of Goods Sold | 90.1M | 82.9M | 85.4M | 75.2M | 46.9M |
| Gross Profit | 150.9M | 133.2M | 133.7M | 109.1M | 87.0M |
| Operating Expenses | 134.5M | 130.8M | 130.4M | 104.4M | 74.7M |
| Operating Income | 16.3M | 2.5M | 3.3M | 4.7M | 12.4M |
| Pre-tax Income | 6.0M | -275.6M | -389.0K | 3.6M | 2.3M |
| Income Tax | 7.9M | -21.4M | -1.3M | 1.7M | -971.0K |
| Net Income | -2.0M | -254.2M | 930.0K | 1.9M | 3.3M |
| EPS (Diluted) | - | -$47.20 | $0.17 | $0.35 | $0.64 |
Income Statement Trend
Mesa Laboratories Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 102.7M | 109.4M | 119.0M | 124.3M | 303.7M |
| Non-Current Assets | 330.7M | 337.4M | 542.9M | 583.1M | 297.7M |
| Total Assets | 433.3M | 446.8M | 661.8M | 707.4M | 601.5M |
| Liabilities | |||||
| Current Liabilities | 164.0M | 44.3M | 43.4M | 48.1M | 32.6M |
| Non-Current Liabilities | 109.6M | 257.1M | 225.0M | 265.5M | 162.7M |
| Total Liabilities | 273.5M | 301.4M | 268.4M | 313.6M | 195.2M |
| Equity | |||||
| Total Shareholders Equity | 159.8M | 145.4M | 393.5M | 393.8M | 406.2M |
Balance Sheet Composition
Mesa Laboratories Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -2.0M | -254.2M | 930.0K | 1.9M | 3.3M |
| Operating Cash Flow | 39.7M | -229.4M | 31.9M | 42.6M | 34.5M |
| Investing Activities | |||||
| Capital Expenditures | -4.2M | -2.6M | -4.5M | -4.4M | -2.0M |
| Investing Cash Flow | -4.2M | -81.3M | -9.5M | -305.2M | -2.0M |
| Financing Activities | |||||
| Dividends Paid | -3.5M | -3.4M | -3.4M | -3.3M | -3.2M |
| Financing Cash Flow | -47.2M | 32.5M | -40.3M | 44.5M | 141.3M |
| Free Cash Flow | 42.3M | 41.6M | 23.4M | 34.8M | 35.1M |
Cash Flow Trend
Mesa Laboratories Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
546.59
Forward P/E
11.76
Price to Book
2.95
Price to Sales
1.96
PEG Ratio
11.76
Profitability Ratios
Profit Margin
-0.82%
Operating Margin
2.36%
Return on Equity
-1.29%
Return on Assets
2.50%
Financial Health
Current Ratio
0.63
Debt to Equity
121.29
Beta
0.89
Per Share Data
EPS (TTM)
-$0.36
Book Value per Share
$29.30
Revenue per Share
$44.45
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| mlab | 471.5M | 546.59 | 2.95 | -1.29% | -0.82% | 121.29 |
| Garmin | 41.6B | 28.41 | 5.09 | 19.04% | 22.76% | 2.18 |
| Keysight | 28.2B | 38.42 | 5.13 | 14.30% | 14.53% | 50.48 |
| Faro Technologies | 848.8M | - | 3.25 | -0.34% | -0.26% | 35.44 |
| Ituran Location and | 782.8M | 14.21 | 4.11 | 30.71% | 16.35% | 2.74 |
| Vishay Precision | 378.0M | 123.96 | 1.16 | 0.93% | 1.04% | 16.84 |
Financial data is updated regularly. All figures are in the company's reporting currency.